Patterns of in vitro cell-death, metaloproteinase-9 and pro-inflammatory cytokines in human monocytes induced by the BCG vaccine, moreau strain

Vaccine

Volumn 29, Issue 38, 2011, Pages 6446-6450

  Simas, C J A ^a   Silva, D P H ^a   Ponte, C G G ^a   Castello Branco, L R R ^a   Antas, P R Z ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Apoptosis, Cytokine; BCG vaccine; Tuberculosis, Monocyte

Indexed keywords

BCG VACCINE; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; LIPOCORTIN 5; TUMOR NECROSIS FACTOR ALPHA;

ADULT; APOPTOSIS; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL STRAIN; BCG VACCINATION; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME INDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GROUPS BY AGE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IN VITRO STUDY; MALE; MONOCYTE; MYCOBACTERIUM BOVIS; NEWBORN; NORMAL HUMAN; PRIORITY JOURNAL; TUBERCULOSIS; UMBILICAL VEIN ENDOTHELIAL CELL; ZYMOGRAPHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BCG VACCINE; CELL DEATH; FEMALE; FLOW CYTOMETRY; HUMANS; INFANT, NEWBORN; INTERLEUKIN-1BETA; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MONOCYTES; PREGNANCY; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 80051671000     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.06.093     Document Type: Article

References (20)

1. Lawn S.D., Zumla A.I. Tuberculosis. Lancet 2011, 378(9785):57-72.
2. World Health Organization. Global tuberculosis control: epidemiology, strategy, financing report 2009. Report No.: 2009.
3. Colditz G.A. Efficacy of BCG vaccine in prevention of tuberculosis. J Am Med Assoc 1994, 271:698-702.
4. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M.C. Consensus statement and global burden of tuberculosis: estimated incidence, prevalence, and mortality by country: WHO Global Surveillance and Monitoring Project. J Am Med Assoc 1999, 282:677-686.
5. Keane J., Balcewicz-Sablinska M.K., Remold H.G., Chupp G.L., Meek B.B., Fenton M.J., et al. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect Immun 1997, 65(1):298-304.
6. Fratazzi C., Arbeit R.D., Carini C., Balcewicz-Sablinska M.K., Keane J., Kornfeld H., et al. Macrophage apoptosis in mycobacterial infections. J Leukoc Biol 1999, 66(5):763-764.
7. Lee C.W., Lin C.C., Lin W.N., Liang K.C., Luo S.F., Wu C.B., et al. TNF-alpha induces MMP-9 expression via activation of Src/EGFR. PDGFR/PI3K/Akt cascade and promotion of NF-κB/p300 binding in human tracheal smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2007, 292:799-812.
8. Friedlander R.M., Gagliardini V., Rotello R.J., Yuan J. Functional role of interleukin 1b (IL-1b) in IL-lb-converting enzyme-mediated apoptosis. J Exp Med 1996, 184(2):717-724.
9. Hernandez M.O., Neves I., Sales J.S., Carvalho D.S., Sarno E.N., Sampaio E.P. Induction of apoptosis in monocytes by Mycobacterium leprae in vitro: a possible role for tumor necrosis factor-alpha. Immunology 2003, 109(1):156-164.
10. Sly L.M., Hingley-Wilson S.M., Reiner N.E., McMaster W.R. Survival of Mycobacterium tuberculosis in host macrophages involves resistance to apoptosis dependent upon induction of antiapoptotic Bcl-2 family member Mcl-1. J Immunol 2003, 170(1):430-437.
11. Danelishvili L., McGarvey J., Li Y.J., Bermudez L.E. Mycobacterium tuberculosis infection causes different levels of apoptosis and necrosis in human macrophages and alveolar epithelial cells. Cell Microbiol 2003, 5(9):649-660.
12. Behar S.M., Divangahi M., Remold H.G. Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy?. Nat Rev Microbiol 2010, 8:668-674.
13. Fink S.L., Cookson B.T. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun 2005, 73(4):1907-1916.
14. Miao E.A., Leaf I.A., Treuting P.M., Mao D.P., Dors M., Sarkar A., et al. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol 2010, 11(12):1136-1142.
15. Siegrist C.A. Vaccination in the neonatal period and early infancy. Int Rev Immunol 2000, 19:195-219.
16. Levy O. Innate immunity of the human newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007, 7:379-390.
17. Mansoor N., Scriba T.J., de Kock M., Tameris M., Abel B., Keyser A., et al. HIV-1 infection in infants severely impairs the immune response induced by bacille Calmette-Guerin vaccine. J Infect Dis 2009, 199(7):982-990.
18. Benedict C.A. Viruses and the TNF-related cytokines, an evolving battle. Cytokine Growth Factor Rev 2003, 14:3-4.
19. Cohen S.B.A., Perez-Cruz I., Fallen P., Gluckman E., Madrigal J.A. Analysis of the cytokine production by cord and adult blood. Hum Immunol 1999, 60:331-336.
20. Quiding-Jarbrink M., Smith D.A., Bancroft G.J. Production of matrix metalloproteinases in response to mycobacterial infection. Infect Immun 2001, 69(9):5661-5670.